EUVIMEDEUVIMED entdecken
Open Access

Serum Biomarkers of Neuroaxonal and Astroglial Damage in Autism Spectrum Disorder: Relationship With Symptom Severity, Behavioural Dimensions and Age

Zeynep Nur Dedeoğlu iD, Necati Uzun iD, İbrahim Kılınç iD, Ahmet Osman Kılıç iD

International Journal of Developmental Neuroscience · 2026

DOI: 10.1002/jdn.70173 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2026. Verfasst von Zeynep Nur Dedeoğlu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Mengücek Gazi Research and Training Hospital, Department of Child and Adolescent Psychiatry, Binali Yıldırım University, Erzincan, Turkey. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Glial Fibrillary Acidic Protein, Neurofilament Proteins, Astrocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Scientific Research Project Coordination Unit of Necmettin Erbakan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by persistent deficits in social communication and the presence of restrictive, repetitive patterns of behaviour. Although its exact aetiology remains multifaceted and partially understood, recent clinical interest has shifted towards neurobiological substrates, specifically neuroaxonal and astroglial integrity. This study aims to compare serum levels of Neurofilament Light Chain (NfL), Glial Fibrillary Acidic Protein (GFAP), Tau and S100B between children with ASD and healthy controls, while investigating the influence of these biochemical variables on autism severity and behavioural manifestations.

Methods

The study cohort consisted of 44 children (aged 24–72 months) diagnosed with ASD according to DSM‐5‐TR criteria and 40 age‐matched healthy controls. Clinical assessments were conducted using the Childhood Autism Rating Scale (CARS), the Aberrant Behaviour Checklist (ABC) and the Autism Behaviour Checklist. Serum concentrations of the targeted biomarkers were measured using the ELISA method from venous blood samples.

Results

Serum NfL, Tau, GFAP and S100B concentrations did not differ significantly between children with ASD and healthy controls. Exploratory analyses suggested possible associations between selected biomarkers and clinical characteristics; however, these associations did not remain statistically significant after age adjustment and correction for multiple comparisons. Further studies using larger cohorts and ultrasensitive analytical platforms are needed to validate these preliminary findings.

Conclusion

These findings indicate that serum NfL, Tau, GFAP and S100B did not differentiate children with ASD from healthy controls. Exploratory biomarker–clinical associations did not remain statistically significant after age adjustment and correction for multiple comparisons. Larger longitudinal studies using ultrasensitive analytical platforms are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autism Spectrum DisorderGlial Fibrillary Acidic ProteinNeurofilament ProteinsAstrocytesHumansMaleFemaleBiomarkersChildChild, PreschoolS100 Calcium Binding Protein beta Subunittau ProteinsSeverity of Illness IndexCohort Studies

Stichwörter der Autor:innen

S100B proteinautism spectrum disorderglial fibrillary acidic proteinneuroaxonal damageneurofilament light chaintau proteins

Substanzen

BiomarkersGlial Fibrillary Acidic ProteinNeurofilament ProteinsS100 Calcium Binding Protein beta Subunittau Proteinsneurofilament protein LS100B protein, humanGFAP protein, human

Autor:innen und Institutionen

  • Mengücek Gazi Research and Training Hospital, Department of Child and Adolescent Psychiatry, Binali Yıldırım University, Erzincan, Turkey.
  • Meram School of Medicine, Department of Child and Adolescent Psychiatry, Necmettin Erbakan University, Konya, Turkey.

ORCID-Profile: Zeynep Nur Dedeoğlu, Necati Uzun, İbrahim Kılınç, Ahmet Osman Kılıç

Förderung

  • Scientific Research Project Coordination Unit of Necmettin Erbakan University

Zitieren

APA

Dedeoğlu, Z. N., Uzun, N., Kılınç, İ., & Kılıç, A. O. (2026). Serum Biomarkers of Neuroaxonal and Astroglial Damage in Autism Spectrum Disorder: Relationship With Symptom Severity, Behavioural Dimensions and Age. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.70173

Vancouver

Dedeoğlu ZN, Uzun N, Kılınç İ, Kılıç AO. Serum Biomarkers of Neuroaxonal and Astroglial Damage in Autism Spectrum Disorder: Relationship With Symptom Severity, Behavioural Dimensions and Age. International Journal of Developmental Neuroscience. 2026. doi:10.1002/jdn.70173

BibTeX
@article{Dedeolu2026,
  author = {Dedeoğlu, Zeynep Nur and Uzun, Necati and Kılınç, İbrahim and Kılıç, Ahmet Osman},
  title = {Serum Biomarkers of Neuroaxonal and Astroglial Damage in Autism Spectrum Disorder: Relationship With Symptom Severity, Behavioural Dimensions and Age},
  journal = {International Journal of Developmental Neuroscience},
  year = {2026},
  doi = {10.1002/jdn.70173}
}
Kostenlos starten →